This website is intended for UK healthcare professionals only

Vitrakvi logo

VITRAKVI Prescribing Information

VITRAKVI has been authorised under a conditional approval scheme

and Events

and Events

BTOG 2021: NSCLC patient case study



At the recent British Thoracic Oncology Group (BTOG) 2021 conference, Dr Carles Escriu (Clatterbridge Oncology Centre) and Dr Mark Teo (Leeds University Teaching Hospital) reviewed VITRAKVI data and shared the first VITRAKVI NSCLC patient case study.


Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.



Making TRKs with NTRK

Making TRKs with NTRK

Be informed of future content relevant to you

Be informed of future content relevant to you

Opt-in to Bayer

Want to stay in touch?

If you would like us to keep you up to date with details of future webinars and other important news updates, please stay connected using the button below.


Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email:


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.